Trial intelligence / Profile preview

Pregabalin vs Pregabalin + Milnacipran in Fibromyalgia

NCT03905486Completed

Start
Apr 2019
Primary completion
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of milnacipran in fibromyalgia (FM). Primary endpoint: Fibromyalgia Impact Questionnaire at 3 months. Started Apr 2019; status: completed.

02

Drugs

milnacipran
03

Conditions

fibromyalgia (FM)

Beyond the preview

Go deeper on NCT03905486.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03905486.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call